• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Advance of Seriniquinone Analogues as Melanoma Agents.作为黑色素瘤药物的蛇床子醌类似物的研究进展。
ACS Med Chem Lett. 2019 Feb 6;10(2):186-190. doi: 10.1021/acsmedchemlett.8b00391. eCollection 2019 Feb 14.
2
The new seriniquinone glycoside by biological transformation using the deep sea-derived bacterium Bacillus licheniformis KDM612.利用深海来源的地衣芽孢杆菌 KDM612 进行生物转化得到的新型沙雷肽菌素糖苷。
J Antibiot (Tokyo). 2024 Aug;77(8):515-521. doi: 10.1038/s41429-024-00729-z. Epub 2024 May 21.
3
Seriniquinone, a selective anticancer agent, induces cell death by autophagocytosis, targeting the cancer-protective protein dermcidin.丝氨酸醌是一种选择性抗癌剂,通过自噬作用诱导细胞死亡,其作用靶点为具有癌症保护作用的蛋白质皮肤杀菌素。
Proc Natl Acad Sci U S A. 2014 Oct 14;111(41):14687-92. doi: 10.1073/pnas.1410932111. Epub 2014 Sep 30.
4
Preclinical Development of Seriniquinones as Selective Dermcidin Modulators for the Treatment of Melanoma.Seriniquinones 的临床前开发作为治疗黑色素瘤的选择性 Dermcidin 调节剂。
Mar Drugs. 2022 Apr 28;20(5):301. doi: 10.3390/md20050301.
5
Hypoxia-selective antitumor agents. 10. bis(nitroimidazoles) and related Bis(nitroheterocycles): development of derivatives with higher rates of metabolic activation under hypoxia and improved aqueous solubility.缺氧选择性抗肿瘤剂。10. 双(硝基咪唑)及相关双(硝基杂环):开发在缺氧条件下具有更高代谢活化率且水溶性得到改善的衍生物。
J Med Chem. 1995 May 26;38(11):1928-41. doi: 10.1021/jm00011a013.
6
Butitaxel analogues: synthesis and structure-activity relationships.紫杉醇类似物:合成与构效关系
J Med Chem. 1997 Jan 17;40(2):236-41. doi: 10.1021/jm960505t.
7
New anticancer agents mimicking protein recognition motifs.新型抗癌药物模拟蛋白质识别基序。
J Med Chem. 2013 Sep 12;56(17):6666-80. doi: 10.1021/jm400947b. Epub 2013 Aug 19.
8
Cephalostatin analogues--synthesis and biological activity.头霉素类似物——合成与生物活性
Fortschr Chem Org Naturst. 2004;87:1-80. doi: 10.1007/978-3-7091-0581-8_1.
9
Synthesis and anti-melanoma activity of analogues of N-acetyl-4-S-cysteaminylphenol substituted with two methyl groups alpha to the nitrogen.氮原子α位带有两个甲基的N-乙酰基-4-S-半胱氨酰苯酚类似物的合成及其抗黑色素瘤活性
Anticancer Drug Des. 2001 Feb;16(1):49-55.
10
Hypoxia-selective antitumor agents. 9. Structure-activity relationships for hypoxia-selective cytotoxicity among analogues of 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide.缺氧选择性抗肿瘤剂。9. 5-[N,N-双(2-氯乙基)氨基]-2,4-二硝基苯甲酰胺类似物中缺氧选择性细胞毒性的构效关系。
J Med Chem. 1994 Jul 8;37(14):2175-84. doi: 10.1021/jm00040a009.

引用本文的文献

1
The new seriniquinone glycoside by biological transformation using the deep sea-derived bacterium Bacillus licheniformis KDM612.利用深海来源的地衣芽孢杆菌 KDM612 进行生物转化得到的新型沙雷肽菌素糖苷。
J Antibiot (Tokyo). 2024 Aug;77(8):515-521. doi: 10.1038/s41429-024-00729-z. Epub 2024 May 21.
2
Heterocyclic Iminoquinones and Quinones from the National Cancer Institute (NCI, USA) COMPARE Analysis.国家癌症研究所(美国 NCI)比较分析的杂环亚氨基醌和醌。
Molecules. 2023 Jul 4;28(13):5202. doi: 10.3390/molecules28135202.
3
The intriguing chemistry and biology of sulfur-containing natural products from marine microorganisms (1987-2020).海洋微生物含硫天然产物的有趣化学与生物学研究(1987 - 2020年)
Mar Life Sci Technol. 2021 May 19;3(4):488-518. doi: 10.1007/s42995-021-00101-2. eCollection 2021 Nov.
4
Preclinical Development of Seriniquinones as Selective Dermcidin Modulators for the Treatment of Melanoma.Seriniquinones 的临床前开发作为治疗黑色素瘤的选择性 Dermcidin 调节剂。
Mar Drugs. 2022 Apr 28;20(5):301. doi: 10.3390/md20050301.
5
Seriniquinones as Therapeutic Leads for Treatment of BRAF and NRAS Mutant Melanomas.塞里尼醌类作为治疗 BRAF 和 NRAS 突变型黑色素瘤的治疗靶点。
Molecules. 2021 Dec 4;26(23):7362. doi: 10.3390/molecules26237362.
6
Verrucosamide, a Cytotoxic 1,4-Thiazepane-Containing Thiodepsipeptide from a Marine-Derived Actinomycete.海洋来源放线菌中含 1,4-噻嗪烷的细胞毒硫酯肽类化合物疣粒衫醇。
Mar Drugs. 2020 Nov 5;18(11):549. doi: 10.3390/md18110549.
7
Biologically active marine natural products and their molecular targets discovered using a chemical genetics approach.利用化学生物学方法发现具有生物活性的海洋天然产物及其分子靶标。
Nat Prod Rep. 2020 May 1;37(5):617-633. doi: 10.1039/c9np00054b. Epub 2019 Nov 21.

本文引用的文献

1
Cell death-based treatments of melanoma:conventional treatments and new therapeutic strategies.基于细胞死亡的黑色素瘤治疗方法:传统治疗方法和新的治疗策略。
Cell Death Dis. 2018 Jan 25;9(2):112. doi: 10.1038/s41419-017-0059-7.
2
Mitogen-activated protein kinase (MEK) inhibitors to treat melanoma alone or in combination with other kinase inhibitors.丝裂原活化蛋白激酶(MEK)抑制剂,用于单独治疗黑色素瘤或与其他激酶抑制剂联合使用。
Expert Opin Drug Metab Toxicol. 2018 Mar;14(3):317-330. doi: 10.1080/17425255.2018.1432593. Epub 2018 Jan 30.
3
Overcoming resistance to BRAF inhibitors.克服对BRAF抑制剂的耐药性。
Ann Transl Med. 2017 Oct;5(19):387. doi: 10.21037/atm.2017.06.09.
4
BRAF inhibitors: resistance and the promise of combination treatments for melanoma.BRAF抑制剂:黑色素瘤的耐药性及联合治疗的前景
Oncotarget. 2017 Aug 3;8(44):78174-78192. doi: 10.18632/oncotarget.19836. eCollection 2017 Sep 29.
5
The safety and efficacy of dabrafenib and trametinib for the treatment of melanoma.达拉非尼和曲美替尼治疗黑色素瘤的安全性和有效性。
Expert Opin Drug Saf. 2018 Jan;17(1):73-87. doi: 10.1080/14740338.2018.1390562. Epub 2017 Oct 20.
6
New perspectives for targeting RAF kinase in human cancer.针对人类癌症中 RAF 激酶的新视角。
Nat Rev Cancer. 2017 Nov;17(11):676-691. doi: 10.1038/nrc.2017.79. Epub 2017 Oct 6.
7
Small Molecule Drugs and Targeted Therapy for Melanoma: Current Strategies and Future Directions.黑色素瘤的小分子药物与靶向治疗:当前策略与未来方向
Curr Med Chem. 2017;24(21):2312-2344. doi: 10.2174/0929867324666170414163937.
8
Targeted agents and immunotherapies: optimizing outcomes in melanoma.靶向药物和免疫疗法:优化黑色素瘤的治疗效果。
Nat Rev Clin Oncol. 2017 Aug;14(8):463-482. doi: 10.1038/nrclinonc.2017.43. Epub 2017 Apr 4.
9
The discovery of vemurafenib for the treatment of BRAF-mutated metastatic melanoma.维莫非尼治疗 BRAF 突变型转移性黑色素瘤的发现。
Expert Opin Drug Discov. 2016 Sep;11(9):907-16. doi: 10.1080/17460441.2016.1201057. Epub 2016 Jun 23.
10
Subcellular ROS imaging methods: Relevance for the study of calcium signaling.亚细胞活性氧成像方法:对钙信号研究的意义
Cell Calcium. 2016 Aug;60(2):65-73. doi: 10.1016/j.ceca.2016.05.001. Epub 2016 May 4.

作为黑色素瘤药物的蛇床子醌类似物的研究进展。

Advance of Seriniquinone Analogues as Melanoma Agents.

作者信息

Hammons Justin C, Trzoss Lynnie, Jimenez Paula C, Hirata Amanda S, Costa-Lotufo Leticia V, La Clair James J, Fenical William

机构信息

Center for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California, San Diego, La Jolla, California 92093-0204, United States.

Instituto do Mar, Universidade Federal de São Paulo, Santos, São Paulo 11070-100, Brazil.

出版信息

ACS Med Chem Lett. 2019 Feb 6;10(2):186-190. doi: 10.1021/acsmedchemlett.8b00391. eCollection 2019 Feb 14.

DOI:10.1021/acsmedchemlett.8b00391
PMID:30783501
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6378664/
Abstract

Seriniquinone, a marine natural product, displayed potent cytotoxicity and selectivity against melanoma cancer cells. This selectivity, combined with a novel mode of action (MOA), prompted studies to translate a pharmacologically relevant lead. Herein, we report on structure-activity relationships (SARs), and provide a strategy to prepare analogues that retain activity and offer an improved water solubility and isomeric purity. From intermediates made on a gram-scale, derivatives were prepared and evaluated for their antiproliferation activity and melanoma selectivity. Overall these studies provide methods to install side chain motifs that demonstrate a common, and yet unique, biological profile.

摘要

海兔醌,一种海洋天然产物,对黑色素瘤癌细胞显示出强大的细胞毒性和选择性。这种选择性与一种新的作用模式(MOA)相结合,促使开展研究以转化具有药理学相关性的先导化合物。在此,我们报告结构-活性关系(SARs),并提供一种制备保留活性且具有改善的水溶性和异构体纯度的类似物的策略。从克级规模制备的中间体出发,制备了衍生物并评估其抗增殖活性和对黑色素瘤的选择性。总体而言,这些研究提供了安装侧链基序的方法,这些侧链基序展现出一种共同但又独特的生物学特征。